suggested that CXCL10 levels are specifically higher in patients with SSc-ILD compared to SSc patients without lung complications,21 little is known about whether CXCL10 levels systemically (blood) and locally (lungs) correlate and may predict long-term ILD development and/or worsening of lung function. The gene discussed is CXCL10; the disease is systemic sclerosis.